Health Care: Drugs

GTx Inc. (GTXI: NASDAQ)

$1.32 n/a | n/a%
04/17/14 - 04:00 PM ET
Company Profile
Price and Volume
Recent Price 1.32
52 Week High 7.24
52 Week Low 1.26
Avg. Daily Vol. (Mil) 0.60
Beta (3 year) 2.56
Share Related Items
Mkt Cap (Mil) 99.21
Shares Out (Mil) 75.16
Float (Mil) 23.98
Dividend Information
Yield % 0.00
Annual Dividend 0.00
Payout Ratio 0.00
Financial Strength
Quick Ratio 3.20
Current Ratio 3.30
LT Debt/ Equity 0.00
Total Debt / Equity 0.00
Valuation Ratios
Price Earnings n.a.
Price/Sales 0.00
Price/Book 9.29
Price/Cash Flow -2.40
Per Share Data
Earnings -0.67
Sales 0.00
Book Value 0.14
Cash Flow -0.56
Business Summary
GTx, Inc. is biopharmaceutical company dedicated to the discovery, development and commercialization of small molecules that selectively target hormone pathways to treat cancer, osteoporosis and bone loss, muscle loss and other serious medical condition.
General Information
175 Toyota Plaza
7th Floor
Memphis, TN 38103
www.gtxinc.com
Industry : Drugs
Sector: Health Care
Employees: 32
CEO: Mr. Marc S. Hanover
Short Interest
Current Month (Mil) 4.80
Previous Month (Mil) 4.67
Short Interest Ratio (Days) 6.60
Management Effectiveness
Return on Equity n.a.
Return on Assets -269.90
Return on Investments -394.20
Profitability
Gross Margin n.a.
EBIT Margin n.a.
Profit Margin 0.00

Portfolios with GTXI

Latest GTXI Headlines from TheStreet

More Financial News for GTXI

Press Releases for GTXI

See All Press Releases

Partner Headlines for GTXI

brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter